Exploring differences in adverse symptom event grading thresholds between clinicians and patients in the clinical trial setting

PURPOSE: Symptomatic adverse event (AE) monitoring is essential in cancer clinical trials to assess patient safety, as well as inform decisions related to treatment and continued trial participation. As prior research has demonstrated that conventional concordance metrics (e.g., intraclass correlati...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Cancer Res Clin Oncol
Päätekijät: Atkinson, Thomas M., Rogak, Lauren J., Heon, Narre, Ryan, Sean J., Shaw, Mary, Stark, Liora P., Bennett, Antonia V., Basch, Ethan, Li, Yuelin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5354957/
https://ncbi.nlm.nih.gov/pubmed/28093637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-016-2335-9
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia